Company Encyclopedia
View More
name
MEDLIVE
02192.HK
Medlive Technology Co., Ltd. operates an online professional physician platform in Mainland China and internationally. The company’s precision marketing and corporate solution provides digital marketing, digital detailing, digital marketing consultation, digital content creation, application software development, and other relevant services. Its medical knowledge solution offers medical education and clinical decision support, including licensing software to physicians and other registered users, such as other healthcare professionals and pharmaceutical companies.
33.02 B
02192.HKMarket value -Rank by Market Cap -/-

Financial Score

16/12/2025 Update
B
Health Care TechnologyIndustry
Industry Ranking1/7
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE6.80%C
    • Profit Margin51.63%A
    • Gross Margin58.95%B
  • Growth ScoreB
    • Revenue YoY30.31%A
    • Net Profit YoY11.70%C
    • Total Assets YoY5.30%B
    • Net Assets YoY5.46%B
  • Cash ScoreB
    • Cash Flow Margin193.67%C
    • OCF YoY30.31%A
  • Operating ScoreE
    • Turnover0.12E
  • Debt ScoreA
    • Gearing Ratio4.19%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    MEDLIVE issued 534,500 shares due to the exercise of stock options

    According to an announcement by MEDLIVE, the company will issue 534,500 shares of common stock to one of its directors exercising stock options under the pre-IPO stock option plan adopted on March 29, 2021, on October 15, 2025

    Zhitong·
    HK
    02192
    -3.59%
    Zhitong·
    HK
    02192
    -3.59%

    Medlive Technology Co. Ltd. Reports Net Profit Increase to RMB160.4 Million and Revenue Growth in 2025 Interim Results

    Medlive Technology Co. Ltd. reported a net profit increase to RMB160.4 million for the six months ended June 30, 2025, up from RMB152.7 million in 2024. The net profit margin was 51.4%, with an adjusted net profit of RMB166.7 million. The company focuses on precision marketing solutions for the healthcare sector and launched a clinical case database in April. Medlive is enhancing its platform using AI and expanding its clinical research services in various specialties, reflecting its commitment to innovative drug commercialization and strategic partnerships.

    Reuters·
    HK
    02192
    -3.59%
    Reuters·
    HK
    02192
    -3.59%

    Zhitong Hong Kong Stock Investment Journal | September 5

    On September 5, 2025, the investment log of Hong Kong-listed companies is as follows: Category Company Earnings Announcement Date Emperor International Investment Shareholders Meeting Date Huaying Holdings VICON HOLDINGS Meitu Acer Capital Jiatao (Hong Kong) Holdings Fenmei Packaging Chuncheng Thermal Power Huayin International Holdings Kuaiji Intelligent Yuga International Holdings Dividend Distribution Beikong Urban Resources (Ex-dividend Date) New Media Planning (Ex-dividend Date) Haidilao (Ex-dividend Date) MEDLIVE (Ex-dividend Date) Yihai International (Ex-dividend Date) China Merchants Commercial REIT (Ex-dividend Date) China Coal Energy (Ex-dividend Date) Longji Group (Ex-dividend Date) Haohai Biotechnology (Ex-dividend Date) AIA (Ex-dividend Date) Smoore International (Ex-dividend Date) Baifu Global (Ex-dividend Date) Wanwu Cloud (Ex-dividend Date) CITIC International Telecom (Ex-dividend Date) Qifu Technology-S (Ex-dividend Date) Cabin (Dividend Date) China Tower (Ex-dividend Date) PCCW (Dividend Date) Perfect Medical (Dividend Date) Tongdeshi (Group) (Ex-dividend Date) Kuang Wenji (Ex-dividend Date) Yidu (International Holdings) (Ex-dividend Date) Economic Daily Group (Dividend Date)

    Zhitong·
    HK
    02192
    -3.59%
    Zhitong·
    HK
    02192
    -3.59%

    Fidelity Fund increased its holdings in MEDLIVE by 1.6715 million shares at a price of approximately HKD 14.51 per share

    According to the latest data from the Hong Kong Stock Exchange, on August 27, Franklin Templeton increased its holdings in MEDLIVE by 1.6715 million shares, at a price of HKD 14.5086 per share, for a total amount of approximately HKD 24.2511 million. After the increase, the latest number of shares held is 37.3465 million, with a shareholding ratio of 5.09%

    Zhitong·
    HK
    02192
    -3.59%
    Zhitong·
    HK
    02192
    -3.59%

    HSBC raises MEDLIVE's target price to 14 yuan, business execution remains on track

    HSBC Global Research Report pointed out that MEDLIVE's business progressed smoothly in the first half of the year, with the number of medical products covered increasing by approximately 32% year-on-year. HSBC raised its adjusted net profit forecast for the fiscal year 2025 by 6% to 21%, and increased the target price from HKD 13.5 to HKD 14, maintaining a "Hold" rating. HSBC believes that artificial intelligence tools will enhance MEDLIVE's understanding of user behavior and marketing efficiency, which will be beneficial for its digital marketing business in the long term

    AASTOCKS·
    HK
    02192
    -3.59%
    AASTOCKS·
    HK
    02192
    -3.59%
    © 2025 Longbridge｜Disclaimer